You are here

  • Home
  • Archive
  • Volume 3, Issue 1
  • The Efficacy of Sodium-Glucose Cotransporter 2 (SGLT2) inhibitors for the treatment of chronic diabetic macular oedema in vitrectomised eyes: a retrospective study

Article metrics

Article menu

Download PDFPDF

XML
Original article
The Efficacy of Sodium-Glucose Cotransporter 2 (SGLT2) inhibitors for the treatment of chronic diabetic macular oedema in vitrectomised eyes: a retrospective study

 

Online download statistics by month:

Online download statistics by month: July 2018 to March 2024

AbstractFullPdf
Jul 2018727210
Aug 201818118136
Sep 201831031058
Oct 201816316326
Nov 201819519522
Dec 201820720721
Jan 201917317213
Feb 201917617123
Mar 201913413123
Apr 201911911922
May 201911611328
Jun 20191009835
Jul 2019999839
Aug 2019353530
Sep 2019373722
Oct 2019383716
Nov 2019565426
Dec 2019686338
Jan 2020575622
Feb 2020272520
Mar 2020484711
Apr 2020191912
May 2020161613
Jun 202024236
Jul 202028269
Aug 202013147
Sep 2020403711
Oct 2020313111
Nov 2020222213
Dec 2020353422
Jan 202112411646
Feb 2021252321
Mar 2021343411
Apr 2021212012
May 2021434013
Jun 202124239
Jul 2021161611
Aug 2021151614
Sep 2021272614
Oct 2021252428
Nov 2021757125
Dec 20211391395
Jan 20221771769
Feb 202212012314
Mar 202210010213
Apr 20221021019
May 202212912715
Jun 2022756910
Jul 20221061066
Aug 202212111610
Sep 2022757413
Oct 2022979612
Nov 2022798115
Dec 202264696
Jan 2023778319
Feb 202310811313
Mar 2023646311
Apr 202314127
May 2023252312
Jun 202314137
Jul 202318147
Aug 2023282313
Sep 202329278
Oct 202311127
Nov 2023212010
Dec 2023201122
Jan 202413135
Feb 2024201911
Mar 2024413360
Total495548731198